Zhejiang Shouxiangu Pharm Co (603896) — Cash Flow-to-Debt Ratio
Zhejiang Shouxiangu Pharm Co (603896) has a Cash Flow-to-Debt Ratio of 0.02x as of September 2025, meaning its operating cash flow of CN¥20.94 Million could theoretically repay 0% of its total liabilities (CN¥841.89 Million) in one year. See Zhejiang Shouxiangu Pharm Co (603896) flexibility index to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Zhejiang Shouxiangu Pharm Co Cash Flow-to-Debt Ratio (2012–2025)
Historical debt coverage capacity for Zhejiang Shouxiangu Pharm Co across 14 annual periods. For the full cash flow conversion analysis, see Zhejiang Shouxiangu Pharm Co cash conversion from operations.
Annual Cash Flow-to-Debt Ratio for Zhejiang Shouxiangu Pharm Co (2012–2025)
Year-by-year debt coverage analysis for Zhejiang Shouxiangu Pharm Co. Check Zhejiang Shouxiangu Pharm Co earnings quality ratio to evaluate the quality of earnings relative to operating cash generation.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.22x | CN¥228.07 Million | CN¥1.02 Billion | ▼ -12.4% |
| 2024 | 0.25x | CN¥213.44 Million | CN¥837.17 Million | ▼ -18.8% |
| 2023 | 0.31x | CN¥315.06 Million | CN¥1.00 Billion | ▼ -12.5% |
| 2022 | 0.36x | CN¥341.28 Million | CN¥950.67 Million | ▼ -58.6% |
| 2021 | 0.87x | CN¥296.70 Million | CN¥342.41 Million | ▲ +26.2% |
| 2020 | 0.69x | CN¥256.36 Million | CN¥373.28 Million | ▼ -44.4% |
| 2019 | 1.24x | CN¥207.92 Million | CN¥168.31 Million | ▲ +48.9% |
| 2018 | 0.83x | CN¥171.51 Million | CN¥206.79 Million | ▼ -57.6% |
| 2017 | 1.96x | CN¥110.80 Million | CN¥56.60 Million | ▲ +259.0% |
| 2016 | 0.55x | CN¥95.52 Million | CN¥175.17 Million | ▲ +52.2% |
| 2015 | 0.36x | CN¥85.03 Million | CN¥237.38 Million | ▼ -37.2% |
| 2014 | 0.57x | CN¥102.90 Million | CN¥180.43 Million | ▼ -4.9% |
| 2013 | 0.60x | CN¥65.85 Million | CN¥109.85 Million | ▲ +79.3% |
| 2012 | 0.33x | CN¥45.36 Million | CN¥135.64 Million | — |